Transdermal patches are used for chronic pain, whereas transmucosal dosage is used for breakthrough cancer pain. Based on the study findings, eight strategies were found to have a high impact on preventing the diversion of prescription opioids in opioid dependence treatment programmes. Those measures included: (a) supervising consumption among those patients most likely to misuse or divert, while providing extended take-home medications only for patients when their dosage and social situation are stable and who accept abuse deterrent formulations, and (b) restricting take-home formulations that could put children at risk through unintentional exposure.